NKTR-181 FDA Approval Status
Last updated by Judith Stewart, BPharm on Jan 20, 2020.
FDA Approved: No (Discontinued)
Brand name: NKTR-181
Generic name: oxycodegol
Company: Nektar Therapeutics
Treatment for: Pain
Development Status: NDA Withdrawn
NKTR-181 (oxycodegol) is a novel mu-opioid agonist molecule designed to have a slow rate of entry into the brain thus reducing abuse potential and CNS-mediated side effects. NKTR-181 is in development for the treatment of chronic low back pain in adult patients new to opioid therapy.
Development timeline for NKTR-181
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.